Compare TEVA & PRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TEVA | PRU |
|---|---|---|
| Founded | 1901 | 1875 |
| Country | Israel | United States |
| Employees | 32842 | 36824 |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1B | 37.6B |
| IPO Year | N/A | N/A |
| Metric | TEVA | PRU |
|---|---|---|
| Price | $31.15 | $119.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 15 |
| Target Price | $38.63 | ★ $103.71 |
| AVG Volume (30 Days) | ★ 4.2M | 1.4M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.97 | $3.06 |
| P/E Ratio | $28.19 | ★ $10.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.99 | $91.89 |
| 52 Week High | $37.35 | $120.59 |
| Indicator | TEVA | PRU |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 70.61 |
| Support Level | $30.59 | $99.97 |
| Resistance Level | $32.40 | N/A |
| Average True Range (ATR) | 0.92 | 2.14 |
| MACD | -0.15 | 0.13 |
| Stochastic Oscillator | 34.13 | 91.40 |
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.